Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention

Clinical trial NCT02430259 · COMPLETED

Trial details

NCT number: NCT02430259
Sponsor: Huashan Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Silicosis Tuberculosis

Start date: 2015-03-01
Primary completion: 2018-06-01
Enrollment: 566

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.